Latest News
Conference Coverage
Preventive upstream therapy prevents progression of atrial fib
BARCELONA – RACE 3 results highlight benefits of risk factor intervention.
Conference Coverage
A Fib ablation surpasses drugs for improving quality of life
Treatment of paroxysmal or persistent atrial fibrillation with ablation led to a significantly better improvement of quality of life compared with...
News from the FDA/CDC
Young adults lead the ranks of recently insured
Since 2010, Americans aged 18-29 years have seen a larger drop in their uninsured rate than those younger and older.
Conference Coverage
VIDEO: Clopidogrel bests ticagrelor in PCI for ACS in real-world study
BARCELONA – Fewer adverse events seen with less potent platelet inhibition in contemporary practice in CHANGE DAPT.
Conference Coverage
VIDEO: Anacetrapib doubles HDL, but patients gain from its modest LDL cut
BARCELONA – Parsing the CTEP inhibitor’s means of conferring benefit proves elusive.
Conference Coverage
VIDEO: Prescription-strength ibuprofen worsens blood pressure more than other NSAIDs
BARCELONA – Celecoxib performs best in PRECISION-ABPM trial.
Conference Coverage
Forgo supplemental oxygen in adequately perfused patients with acute MI, study suggests
Supplemental oxygen shows no benefit in no-hypoxemia patients with acute MI.
From the Journals
In T1 diabetes, CABG seems better than PCI
An observational study shows worse outcomes for PCI among type 1 diabetes patients who require multivessel revascularization, but the researchers...
Conference Coverage
Undiagnosed AF common in higher-risk patients
Patients at high risk of atrial fib and stroke commonly have undiagnosed AF.
News
Liraglutide approved for cardiovascular event reduction
Victoza (liraglutide) has a new indication from the FDA to reduce risk of several adverse cardiovascular events.
From the Journals
Intraoperative ketamine makes no dent in postop delirium or pain
Postoperative delirium remains a problem without an effective solution.